help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adachi, H.
Right arrow Articles by Miyake, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adachi, H.
Right arrow Articles by Miyake, A.

Endocrinology, Vol 135, 1824-1830, Copyright © 1994 by Endocrine Society


ARTICLES

Epidermal growth factor promotes adipogenesis of 3T3-L1 cell in vitro

H Adachi, H Kurachi, H Homma, K Adachi, T Imai, K Morishige, Y Matsuzawa and A Miyake
Department of Obstetrics and Gynecology, Osaka University Medical School, Japan.

We have reported the importance of epidermal growth factor (EGF) for the induction of obesity in mice. In this study, we studied the effects of EGF on the induction of lipogenic enzymes and on the accumulation of triglyceride in a differentiated mouse adipocyte cell in vitro. Mouse 3T3-L1 preadipocytic cells differentiated into mature adipocytes after the differentiation procedure by insulin, dexamethasone, and methyl- isobutyl-xanthine. 125I-EGF binding studies in the differentiated 3T3- L1 cells showed specific 125I-EGF bindings, and they expressed gene transcripts for EGF receptors by reverse transcription and polymerase chain reaction at all differentiative stages examined. Although EGF showed inhibitory effects on the triglyceride accumulation when administered to the preadipocytic 3T3-L1 cells, EGF enhanced the adipogenesis in the differentiated cells in dose- and time-dependent manners. Administration of EGF at 0.1-1 nM from 4 days after the differentiation procedure for 10 days, significantly enhanced the acyl- Co A synthetase and lipoprotein lipase messenger RNA levels, both of which are rate-limiting enzymes to synthesize triglyceride in adipocytes. Moreover, 0.1-1 nM EGF increased the amounts of triglyceride accumulated in the cells, in proportion to the acyl-Co A synthetase and lipoprotein lipase messenger RNA levels. EGF rather failed the adipogenesis at 10 nM. Time course studies revealed that 1 nM EGF significantly increased the intracellular triglyceride levels from 4 through 16 days administration. These results suggest that EGF shows biphasic effects on adipocytes: although EGF inhibits preadipocytes differentiation into mature adipocytes, it promotes adipogenesis in the differentiated adipocytes.


This article has been cited by other articles:


Home page
J BiochemHome page
N. Nakano, N. Miyazawa, T. Sakurai, T. Kizaki, K. Kimoto, K. Takahashi, H. Ishida, M. Takahashi, K. Suzuki, and H. Ohno
Gliclazide Inhibits Proliferation but Stimulates Differentiation of White and Brown Adipocytes
J. Biochem., November 1, 2007; 142(5): 639 - 645.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Meng, J. Zhou, H. Sasano, T. Suzuki, K. M. Zeitoun, and S. E. Bulun
Tumor Necrosis Factor {{alpha}} and Interleukin 11 Secreted by Malignant Breast Epithelial Cells Inhibit Adipocyte Differentiation by Selectively Down-Regulating CCAAT/Enhancer Binding Protein {{alpha}} and Peroxisome Proliferator-activated Receptor {{gamma}}: Mechanism of Desmoplastic Reaction
Cancer Res., March 1, 2001; 61(5): 2250 - 2255.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
F. Tebar, M. Grau, M.-P. Mena, A. Arnau, M. Soley, and I. RamIrez
Epidermal Growth Factor Secreted from Submandibular Salivary Glands Interferes with the Lipolytic Effect of Adrenaline in Mice
Endocrinology, March 1, 2000; 141(3): 876 - 882.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Nanbu-Wakao, Y. Fujitani, Y. Masuho, M.-a. Muramatu, and H. Wakao
Prolactin Enhances CCAAT Enhancer-Binding Protein-{beta} (C/EBP{beta}) and Peroxisome Proliferator-Activated Receptor {gamma} (PPAR{gamma}) Messenger RNA Expression and Stimulates Adipogenic Conversion of NIH-3T3 Cells
Mol. Endocrinol., February 1, 2000; 14(2): 307 - 316.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. S. Camp and S. R. Tafuri
Regulation of Peroxisome Proliferator-activated Receptor gamma Activity by Mitogen-activated Protein Kinase
J. Biol. Chem., April 18, 1997; 272(16): 10811 - 10816.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society